Health3 weeks ago
Cabaletta Bio Reports Positive CAR-T Trial Results for Autoimmunity
Cabaletta Bio, a Philadelphia-based biotechnology company, has announced promising results from its recent clinical trial involving CAR-T therapy for a rare autoimmune disorder. The findings indicate...
